Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-30 @ 3:22 AM
Study NCT ID:
NCT05204368
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-16
First Post:
2022-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)
Sponsor:
Evopoint Biosciences Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-05
First Submit QC Date:
None
Study First Post Date:
2022-01-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-15
Last Update Post Date:
2023-02-16
Last Update Post Date Type:
ACTUAL